Glyn Edwards
@cordulegaster.bsky.social
Biotech, wildlife, science, ingenuity
Interesting news from MitoRx this morning. Developing obesity treatments that have a very different mechanism to GLO-1s.
www.mitorxtherapeutics.com/press/mitorx...
www.mitorxtherapeutics.com/press/mitorx...
MitoRx Therapeutics
www.mitorxtherapeutics.com
November 17, 2025 at 4:15 PM
Interesting news from MitoRx this morning. Developing obesity treatments that have a very different mechanism to GLO-1s.
www.mitorxtherapeutics.com/press/mitorx...
www.mitorxtherapeutics.com/press/mitorx...
Reposted by Glyn Edwards
#medsky#pedsky#idsky#immunosky 🧪
In the midst of all of the scary headlines recently, I thought I could take a moment to share a bit of good news: for the first time in history, a malaria vaccine with >90% efficacy seems to be within reach!
Here’s why that’s a really big deal for EVERYONE 🧵
In the midst of all of the scary headlines recently, I thought I could take a moment to share a bit of good news: for the first time in history, a malaria vaccine with >90% efficacy seems to be within reach!
Here’s why that’s a really big deal for EVERYONE 🧵
A Single-Dose Breakthrough: PfSPZ-LARC Vaccines Offer Transformative Protection Against Malaria – Sanaria
sanaria.com
February 13, 2025 at 1:23 PM
#medsky#pedsky#idsky#immunosky 🧪
In the midst of all of the scary headlines recently, I thought I could take a moment to share a bit of good news: for the first time in history, a malaria vaccine with >90% efficacy seems to be within reach!
Here’s why that’s a really big deal for EVERYONE 🧵
In the midst of all of the scary headlines recently, I thought I could take a moment to share a bit of good news: for the first time in history, a malaria vaccine with >90% efficacy seems to be within reach!
Here’s why that’s a really big deal for EVERYONE 🧵
Thought provoking
November 9, 2024 at 9:22 AM
Thought provoking
Interesting data from Aneta Stachowicz on use of mitochondrial targeted sulfide donors in high fat diet mice. www.sciencedirect.com/science/arti...
Mitochondria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathway...
Metabolic diseases that include obesity and metabolic-associated fatty liver disease (MAFLD) are a rapidly growing worldwide public health problem. Th…
www.sciencedirect.com
October 10, 2024 at 11:43 AM
Interesting data from Aneta Stachowicz on use of mitochondrial targeted sulfide donors in high fat diet mice. www.sciencedirect.com/science/arti...